Almac achieves full GMP compliance across global sites

Published: 19-Dec-2008 Featured companies: Almac Group
Packaging Regulatory

Almac Clinical Services has completed a successful inspection of its Durham, North Carolina, US operations by the UK Medicines and Healthcare products Regulatory Agency (MHRA).


Almac Clinical Services has completed a successful inspection of its Durham, North Carolina, US operations by the UK Medicines and Healthcare products Regulatory Agency (MHRA).

This was the final inspection covering the group’s main sites for clinical supplies and follows those performed at its Craigavon (UK) and Audubon (US) facilities within the last four months.

The voluntary inspection, which took place in November, observed that the Durham site was fully compliant with EU Good Manufacturing Practices, with no critical or major failures noted.

Commenting on the global significance of the inspections, Paul O’Connor, vice president of quality, said: ‘The inspection at our Durham site is the third and final outcome in demonstrating global GMP compliance for Almac Clinical Services. Once again we have proven our company wide attitude towards a total quality ethos and this has been reflected in the results of the recent inspections.’

Almac Clinical Services is focused on clinical trial supply solutions. Services provided include blinding, packaging, labelling, global distribution, QP release, analytical testing, drug supply management and online randomisation.

Featured companies

See more

You may also like

Manufacturing

Almac completes “outstanding” grade by the KTP

Read more
The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development

Trending Articles

  1. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  2. 4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group
  3. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  4. Why do pharmaceutical glass containers break? The underestimated power of strength testing and fractography
  5. Flexicon optimises Rossix’s small batch filling and capping process Rossix has optimised its batch filling and capping process by using a peristaltic filler of the PF series and a FlexFeed30 tabletop bottle handling and capping system from Flexicon Liquid Filling

Relevant companies

See more

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Almac completes “outstanding” grade by the KTP

The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development
Manufacturing

Almac Sciences Ireland secures HPRA certification

This additional certification enables Almac to perform biologics testing for the determination of product quality attributes
Regulatory

Almac receives product approval by MHRA and Health Canada

The company’s site provides a range of solutions for blister packs, stickpacks, and kitting
Packaging

Enhancing clinical trial supply with JTM: part I

In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a rapidly growing and ageing population and develop innovative personalised medicines. Almac has responded to these demands with a Just-in-Time Manufacturing solution that fulfils the requirements of a high value, time sensitive clinical supply chain. Dr Kevin Robinson spoke to Natalie Balanovsky, Just-in-Time Manufacturing Solutions Manager, and Mark Rohlfing, Vice President of Operations, to find out more
Regulatory

Almac welcomes confirmation that Northern Ireland will remain aligned with the EU post-Brexit

Move offers Almac clients unique, unfettered and flexible access to both the UK and European markets
Regulatory

Almac Group supports two COVID-19 clinical studies in sub-Saharan Africa

Grant awarded from the COVID-19 Therapeutics Accelerator, an Initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard
Manufacturing

Almac Group increases volume of clinical essential supplies to patients at home

Direct to Patient via Site and “Almac to Patient” Services are part of Almac Clinical Services’ ongoing response to COVID-19
Subscribe now